NCT01407523 An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures Status COMPLETED Phase PHASE2
NCT01405508 Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy Status COMPLETED Phase PHASE3
NCT01398956 An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures Status COMPLETED Phase PHASE3
NCT01392768 Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Status COMPLETED Phase PHASE3
NCT01390909 Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database Status COMPLETED Phase N/A
NCT01390220 Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Status TERMINATED Phase PHASE3
NCT01364597 Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy Status COMPLETED Phase PHASE3
NCT01364558 A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01357902 Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China Status COMPLETED Phase PHASE1
NCT01357707 Clinical-genetic Investigations in Children With Early Infantile Epilepsies Status COMPLETED Phase N/A
NCT01339559 Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy Status COMPLETED Phase PHASE3
NCT01336621 Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) Status COMPLETED Phase PHASE3
NCT01332513 An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. Status COMPLETED Phase PHASE1
NCT01320670 Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy Status UNKNOWN Phase N/A